|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions
Bárbara Jaime dos Santos, Débora Balabram, Virginia Mara Reis Gomes, Carolina Costa Café de Castro, Paulo Henrique Costa Diniz, Marcelo Araújo Buzelin, Cristiana Buzelin Nunes
Cancer Res Treat.
2024;56(1):178-190. Published online August 1, 2023 DOI:
https://doi.org/10.4143/crt.2023.386
The Use of CD44 Variant 9 and
Ki-67
Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
Cancer Res Treat.
2019;51(4):1411-1419. Published online February 25, 2019 DOI:
https://doi.org/10.4143/crt.2018.663
Web of Science 12
Crossref 10
VEGF and
Ki-67
Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
Seongyeol Park, Soo Jeong Nam, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, J. Hun Hah, Tack-Kyun Kwon, Dong-Wan Kim, Myung-Whun Sung, Dae Seog Heo, Yung-Jue Bang
Cancer Res Treat.
2016;48(2):518-526. Published online July 14, 2015 DOI:
https://doi.org/10.4143/crt.2015.093
Web of Science 26
Crossref 23
Reduced Expression of E-cadherin in Human Non-small Cell Lung Carcinoma
Na-Hye Myong
Cancer Res Treat.
2004;36(1):56-61. Published online February 29, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.1.56
Crossref 13
Expression of Cyclin-dependent Kinase Inhibitor p21(WAF1/CIP1) in Non-small Cell Lung Carcinomas: Relationship with p53 Status and Proliferative Activity
Na Hye Myong
Cancer Res Treat.
2001;33(4):329-334. Published online August 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.4.329
p27Kipl, K-67 and Bcl-2 Expression in Adenoid Cystic Carcinoma of Head and Neck
C S Choi, G Choi, J J Song, K S Hwang, K Y Jung, J O Choi
J Korean Cancer Assoc.
2000;32(2):382-389.
p 53 Expression in Non - Small Cell Lung Cancer: Its relationship to the clinical prognostic factor and smoking history
Moon Kyung Kim, Han Kyeom Kim, In Sun Kim, Joung Ho Han, Seung Jae Huh, Yong Chan Ahn, Dae Yong Kim, Young Mok Shim
J Korean Cancer Assoc.
1999;31(6):1219-1226.
Prognostic Significance of p53, c-erbB-2, nm23 and
Ki-67
Expression in Patients with Advanced Gastric Carcinoma
Sung Hoon Noh, Chang Hak Yoo, Ho Gune Kim, Young Ha Oh, Jin Sik Min
J Korean Cancer Assoc.
1999;31(4):699-709.
Expression Pattern of
Ki-67
and Apoptosis in Low grade Adenoma of Stomach and Colon
Jae Kyu Lee, Ki Jung Yun, Hyung Bae Moon
J Korean Cancer Assoc.
1999;31(2):411-417.
Significance of Cathepsin D as a Prognostic Factor of Breast Cancer
Dong Wha Lee, Dong Won Kim, So Yeung Jin
J Korean Cancer Assoc.
1996;28(2):261-272.
Effects of Retinoic Acid on p53 Protein , Ki - 67 and PCNA / Cyclin Expression in PLC / PRF / 5 Cells
Dae Gon Kim, Cheol Kwon, Wan Hee Yoo, Yee Yup Kim, Deuk Su Ahn
J Korean Cancer Assoc.
1995;27(4):559-570.
DNA Content and Ki - 67 Antibody Expression by Means of Image Analyzer for Laryngeal Lesions
Hyung Ro Chu, Sun Hee Lee, Jong Ouck Choi, In Sun Kim
J Korean Cancer Assoc.
1994;26(3):466-474.
1
Journal Impact Factor 4.6